Literature DB >> 12083438

Heterosexual outbreak of infectious syphilis: epidemiological and ethnographic analysis and implications for control.

D M Patrick1, M L Rekart, A Jolly, S Mak, M Tyndall, J Maginley, E Wong, T Wong, H Jones, C Montgomery, R C Brunham.   

Abstract

This study describes the epidemiology and ethnography of an outbreak of infectious syphilis in Vancouver, British Columbia. Between 1996 and 1999, British Columbias's rate of infectious syphilis rose from 0.5 to 3.4 per 100,000, with a dense concentration of cases among sex trade workers, their clients, and street-involved people in the downtown eastside area of Vancouver. Sexual networks were imported cases with secondary spread (dyads and triads), large densely connected dendritic networks of sex trade workers and clients, or occasional starburst networks among gay men. Only 232 of 429 partners were documented as having been treated (54% of those named, or 0.9 per case). The geographical and demographic concentration of this outbreak led to consideration of a programme of focused mass treatment with single dose azithromycin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12083438      PMCID: PMC1765833          DOI: 10.1136/sti.78.suppl_1.i164

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  12 in total

1.  Statistical inference to advance network models in epidemiology.

Authors:  David Welch; Shweta Bansal; David R Hunter
Journal:  Epidemics       Date:  2011-01-28       Impact factor: 4.396

2.  Incorporating a social networking approach to enhance contact tracing in a heterosexual outbreak of syphilis.

Authors:  G Ogilvie; L Knowles; E Wong; D Taylor; J Tigchelaar; C Brunt; L James; J Maginley; H Jones; M L Rekart
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

Review 3.  Research on a vulnerable neighborhood-the vancouver downtown eastside from 2001 to 2011.

Authors:  Isabelle Aube Linden; Marissa Y Mar; Gregory R Werker; Kerry Jang; Michael Krausz
Journal:  J Urban Health       Date:  2013-06       Impact factor: 3.671

4.  Molecular typing of Treponema pallidum strains from patients with neurosyphilis in Pretoria, South Africa.

Authors:  J Molepo; A Pillay; B Weber; S A Morse; A A Hoosen
Journal:  Sex Transm Infect       Date:  2007-01-23       Impact factor: 3.519

5.  The characterisation of a recent syphilis outbreak in Sheffield, UK, and an evaluation of contact tracing as a method of control.

Authors:  Selena Singh; Gill Bell; Martin Talbot
Journal:  Sex Transm Infect       Date:  2006-12-06       Impact factor: 3.519

6.  The prevalence and incidence of sexually transmitted infections in a prospective cohort of injection drug users in Vancouver, British Columbia.

Authors:  Laura M Kuyper; Courtney Lc Collins; Thomas Kerr; Robert S Hogg; Kathy Li; Mark W Tyndall; Julio Sg Montaner; Evan Wood
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

7.  Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women.

Authors:  Gina Ogilvie; Mel Krajden; Juanita Maginley; Judy Isaac-Renton; Greg Hislop; Ruth Elwood-Martin; Chris Sherlock; Darlene Taylor; Michael Rekart
Journal:  CMAJ       Date:  2007-08-28       Impact factor: 8.262

8.  Epidemiology of infectious syphilis in Ottawa. Recurring themes revisited.

Authors:  Aviva Leber; Paul MacPherson; B Craig Lee
Journal:  Can J Public Health       Date:  2008 Sep-Oct

9.  Screen more or screen more often? Using mathematical models to inform syphilis control strategies.

Authors:  Ashleigh R Tuite; David N Fisman; Sharmistha Mishra
Journal:  BMC Public Health       Date:  2013-06-24       Impact factor: 3.295

10.  Preliminary development of a scale to measure stigma relating to sexually transmitted infections among women in a high risk neighbourhood.

Authors:  Melanie L A Rusch; Jean A Shoveller; Susan Burgess; Karen Stancer; David M Patrick; Mark W Tyndall
Journal:  BMC Womens Health       Date:  2008-11-20       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.